Ligand Pharmaceuticals (LGND) Treasury Shares (2010 - 2026)

Ligand Pharmaceuticals has disclosed Treasury Shares across 4 years of filings, most recently posting $42.3 million for Q4 2013.

• Treasury Shares for Q4 2013 came in at $42.3 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2013 was $42.3 million (changed 0.0% YoY), and the FY2013 annual result was $42.3 million, changed 0.0% from the prior year.
• Treasury Shares came in at $42.3 million for Q4 2013 at Ligand Pharmaceuticals, roughly flat from $42.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $512361.0 in Q2 2024 to a low of $162152.0 in Q1 2022.
• The 5-year median for Treasury Shares is $437872.0 (2024), against an average of $406604.4.
• Across the five-year window, Treasury Shares increased 0.13% in 2011 and changed 0.0% in 2012, its largest moves.
• Ligand Pharmaceuticals' Treasury Shares stood at $42.2 million in 2010, then grew by 0.13% to $42.3 million in 2011, then changed by 0.0% to $42.3 million in 2012, then changed by 0.0% to $42.3 million in 2013.
• The last three Treasury Shares figures came in at $42.3 million (Q4 2013), $42.3 million (Q3 2013), and $42.3 million (Q2 2013), per Business Quant data.